Amarin reported $298.6M in Ordinary Share Capital for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
DBV Technologies DBVT:US USD 10.71M 1000
Alnylam Pharmaceuticals ALNY:US USD 1.23M 20K
Amarin AMRN:US USD 298.6M 3.94M
AstraZeneca AZN:LN USD 387M 0
Esperion Therapeutics ESPR:US USD 72K 7K
GlaxoSmithKline GSK:LN GBP 1.35B 0
Halozyme Therapeutics HALO:US USD 135K 3K
Heron Therapeutics HRTX:US USD 1.19M 163K
Intercept Pharmaceuticals ICPT:US USD 41K 11K
IONIS PHARMACEUT IONS:US USD 142K 0
JAZZ PHA JAZZ:US USD 61K 0
Nektar Therapeutics NKTR:US USD 19K 0
Neurocrine Biosciences NBIX:US USD 100K 0
Novartis NOVN:VX USD 878.25M 11.75M
Teva Pharmaceutical Industries TEVA:US USD 57M 0